H Grant Skaggs Jr

Array ( [id] => 5034640 [patent_doc_number] => 20070099179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Method for inducing hepatitis c virus (hcv) replication in vitro, cells and cell lines enabling robust hcv replication and kit therefor' [patent_app_type] => utility [patent_app_number] => 10/564886 [patent_app_country] => US [patent_app_date] => 2004-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 72 [patent_no_of_words] => 23661 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099179.pdf [firstpage_image] =>[orig_patent_app_number] => 10564886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276326 [patent_doc_number] => 20040235777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Methods for regulating hematopoiesis using CpG-oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/876892 [patent_app_country] => US [patent_app_date] => 2004-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 26449 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235777.pdf [firstpage_image] =>[orig_patent_app_number] => 10876892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 232621 [patent_doc_number] => 07598046 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-06 [patent_title] => 'Use of prion conversion modulating agents' [patent_app_type] => utility [patent_app_number] => 10/560978 [patent_app_country] => US [patent_app_date] => 2004-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 11338 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/598/07598046.pdf [firstpage_image] =>[orig_patent_app_number] => 10560978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7142795 [patent_doc_number] => 20050118181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'GB virus C (hepatitis G virus) for the treatment of HIV' [patent_app_type] => utility [patent_app_number] => 10/862061 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 27386 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118181.pdf [firstpage_image] =>[orig_patent_app_number] => 10862061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 31787 [patent_doc_number] => 07790181 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Live attenuated viral vaccines for Eastern Equine Encephalitis virus' [patent_app_type] => utility [patent_app_number] => 10/853952 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14166 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790181.pdf [firstpage_image] =>[orig_patent_app_number] => 10853952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5770298 [patent_doc_number] => 20050266412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Method of amplifying infectious protein' [patent_app_type] => utility [patent_app_number] => 10/854742 [patent_app_country] => US [patent_app_date] => 2004-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7832 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266412.pdf [firstpage_image] =>[orig_patent_app_number] => 10854742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7228599 [patent_doc_number] => 20050255525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Safe method for isolation of prion protein and diagnosis of transmissible spongiform encephalopathies' [patent_app_type] => utility [patent_app_number] => 10/844365 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5403 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20050255525.pdf [firstpage_image] =>[orig_patent_app_number] => 10844365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7427711 [patent_doc_number] => 20040265904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Diagnostic method' [patent_app_type] => new [patent_app_number] => 10/493572 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6121 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265904.pdf [firstpage_image] =>[orig_patent_app_number] => 10493572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7341305 [patent_doc_number] => 20040191214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Nucleoside vaccine adjuvants' [patent_app_type] => new [patent_app_number] => 10/475718 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4249 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191214.pdf [firstpage_image] =>[orig_patent_app_number] => 10475718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 809837 [patent_doc_number] => 07416842 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-26 [patent_title] => 'DNA virus microRNA' [patent_app_type] => utility [patent_app_number] => 10/819098 [patent_app_country] => US [patent_app_date] => 2004-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 9184 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/416/07416842.pdf [firstpage_image] =>[orig_patent_app_number] => 10819098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7045510 [patent_doc_number] => 20050250105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Multiple viral replicon culture systems' [patent_app_type] => utility [patent_app_number] => 10/809226 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9464 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250105.pdf [firstpage_image] =>[orig_patent_app_number] => 10809226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 373127 [patent_doc_number] => 07473430 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-06 [patent_title] => 'Cancer cell targeting gene delivery method' [patent_app_type] => utility [patent_app_number] => 10/578839 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 8906 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/473/07473430.pdf [firstpage_image] =>[orig_patent_app_number] => 10578839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4779350 [patent_doc_number] => 20080287348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Soluble Hybrid Prion Proteins And Their Use In The Diagnosis, Prevention And Treatment Of Transmissible Spongiform Encephalopathies' [patent_app_type] => utility [patent_app_number] => 10/549086 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13050 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20080287348.pdf [firstpage_image] =>[orig_patent_app_number] => 10549086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4999351 [patent_doc_number] => 20070041985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Modulation of the poliovirus receptor function' [patent_app_type] => utility [patent_app_number] => 10/546703 [patent_app_country] => US [patent_app_date] => 2004-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 22153 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20070041985.pdf [firstpage_image] =>[orig_patent_app_number] => 10546703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 543136 [patent_doc_number] => 07163806 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-16 [patent_title] => 'Somatic cells with ablated PrP gene and methods of use' [patent_app_type] => utility [patent_app_number] => 10/773795 [patent_app_country] => US [patent_app_date] => 2004-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10648 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/163/07163806.pdf [firstpage_image] =>[orig_patent_app_number] => 10773795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7296236 [patent_doc_number] => 20040214285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'HIV-specific fusion proteins and therapeutic and diagnostic methods for use' [patent_app_type] => new [patent_app_number] => 10/768932 [patent_app_country] => US [patent_app_date] => 2004-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9720 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214285.pdf [firstpage_image] =>[orig_patent_app_number] => 10768932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275052 [patent_doc_number] => 20040234503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Materials and methods relating to improved vaccinations strategies' [patent_app_type] => new [patent_app_number] => 10/485074 [patent_app_country] => US [patent_app_date] => 2004-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12178 [patent_no_of_claims] => 141 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234503.pdf [firstpage_image] =>[orig_patent_app_number] => 10485074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7103431 [patent_doc_number] => 20050106157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Immunogenic formulations comprising oil bodies' [patent_app_type] => utility [patent_app_number] => 10/757720 [patent_app_country] => US [patent_app_date] => 2004-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21311 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106157.pdf [firstpage_image] =>[orig_patent_app_number] => 10757720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7307524 [patent_doc_number] => 20040141999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Antiviral and antiretroviral radioimmunomedicaments based on (alpha)-emitters and (beta)-emitters' [patent_app_type] => new [patent_app_number] => 10/752563 [patent_app_country] => US [patent_app_date] => 2004-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11740 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20040141999.pdf [firstpage_image] =>[orig_patent_app_number] => 10752563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7333590 [patent_doc_number] => 20040131701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs' [patent_app_type] => new [patent_app_number] => 10/740816 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7154 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20040131701.pdf [firstpage_image] =>[orig_patent_app_number] => 10740816 [rel_patent_id] =>[rel_patent_doc_number] =>)